• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[凝血酶的细胞受体]

[Cellular receptor of thrombin].

作者信息

Lasne D, Rendu F, Aiach M

机构信息

Laboratoire d'hémostase, hôpital Broussais, Paris, France.

出版信息

Ann Biol Clin (Paris). 1994;52(4):257-60.

PMID:7802348
Abstract

Thrombin is a serine protease able to evoke biological responses from a variety of cells, including platelets, endothelial cells, fibroblasts and smooth muscle cells. The structure of the thrombin receptor present in the human megakaryoblastic cell line and in hamster fibroblasts has recently been deduced by expression in the Xenopus laevis oocyte. The cloned receptor is a new member of the seven transmembrane domain receptor family that interacts with G proteins. A large amino-terminal extracellular extension has a cleavage site for thrombin (Leu Asp Pro Arg/Ser Phe Leu Leu,/representing the cleavage site). Thrombin cleaves at this site, unmasking a new amino terminus, that functions like a ligand, binding to an as yet undefined site and eliciting receptor activation. Peptides similar to a new amino terminus created after cleavage are able to mimic thrombin cellular effects. These agonist peptides are used to analyse the role of the cloned receptor in the thrombin-specific response.

摘要

凝血酶是一种丝氨酸蛋白酶,能够引发包括血小板、内皮细胞、成纤维细胞和平滑肌细胞在内的多种细胞的生物学反应。最近,通过在非洲爪蟾卵母细胞中表达,推断出了人巨核母细胞系和仓鼠成纤维细胞中存在的凝血酶受体的结构。克隆的受体是与G蛋白相互作用的七跨膜结构域受体家族的新成员。一个大的氨基末端细胞外延伸部分有一个凝血酶切割位点(亮氨酸-天冬氨酸-脯氨酸-精氨酸/丝氨酸-苯丙氨酸-亮氨酸-亮氨酸,/代表切割位点)。凝血酶在此位点切割,暴露出一个新的氨基末端,其功能类似于配体,与一个尚未明确的位点结合并引发受体激活。与切割后产生的新氨基末端相似的肽能够模拟凝血酶的细胞效应。这些激动剂肽用于分析克隆受体在凝血酶特异性反应中的作用。

相似文献

1
[Cellular receptor of thrombin].[凝血酶的细胞受体]
Ann Biol Clin (Paris). 1994;52(4):257-60.
2
Release of the thrombin receptor (PAR-1) N-terminus from the surface of human platelets activated by thrombin.凝血酶激活的人血小板表面凝血酶受体(PAR-1)N端的释放。
Thromb Haemost. 1997 Sep;78(3):1119-24.
3
Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.纤溶酶对蛋白酶激活受体1(PAR1)凝血酶受体的脱敏作用:动力学、截短位点及其对溶栓治疗的意义。
Biochemistry. 1999 Apr 6;38(14):4572-85. doi: 10.1021/bi9824792.
4
Domains specifying thrombin-receptor interaction.
Nature. 1991 Oct 17;353(6345):674-7. doi: 10.1038/353674a0.
5
Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.凝血酶及受体衍生肽在血小板和CHRF-288细胞膜中对凝血酶受体的激活作用:受体刺激的GTP酶以及激动剂和部分激动剂的评估
Mol Pharmacol. 1996 Jan;49(1):190-7.
6
Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.中性粒细胞蛋白酶可使人类PAR3失活,并消除PAR3在小鼠血小板上的共受体功能。
Thromb Haemost. 2001 Mar;85(3):533-8.
7
Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface.凝血酶受体对激动剂肽的特异性由其细胞外表面决定。
Nature. 1994 Apr 14;368(6472):648-51. doi: 10.1038/368648a0.
8
Differential roles of two consecutive phenylalanine residues in thrombin receptor-tethered ligand peptides (SFFLRNP) in thrombin receptor activation.
Biochem Biophys Res Commun. 1994 Aug 30;203(1):366-72. doi: 10.1006/bbrc.1994.2191.
9
Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.蛋白酶激活受体-1可介导凝血酶脱敏细胞对SFLLRN的反应:PAR1的拴系配体阻止或终止信号传导新机制的证据。
Biochemistry. 1999 Feb 23;38(8):2486-93. doi: 10.1021/bi982527i.
10
Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.蛋白酶激活受体-2(PAR-2):与拴系配体表位相关的多种肽激活受体的结构-功能研究
Arch Biochem Biophys. 2001 Feb 15;386(2):195-204. doi: 10.1006/abbi.2000.2207.